Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis — Andrea C. Tricco (2014) | RDL Network
Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis
Brian Hutton, Jennifer Tetzlaff, Fatemeh Yazdi, J. Thielman, Salmaan Kanji, Dean Fergusson, Lise M. Bjerre, Edward J. Mills, Kristian Thorlund, Andrea C. Tricco, Sharon E. Straus, David Moher, Frans H. H. Leenen
Andrea C. Tricco, Jesmin Antony, Veroniki A Angeliki, Huda Ashoor, Brian Hutton, Brenda R. Hemmelgarn, David Moher, Yaron Finkelstein, Kevin Gough, Sharon E. Straus
Katarzyna Nabrdalik, Mirela Hendel, Krzysztof Irlik, Hanna Kwiendacz, Igor Łoniewski, Tommaso Bucci, Uazman Alam, Professor Gregory Lip, Janusz Gumprecht, Karolina Skonieczna‐Żydecka
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.